Melisa Brower is an associate in the Compensation, Governance and ERISA practice.
She focuses on a wide variety of compensation-related matters in capital markets and M&A transactions, with emphasis on disclosure and issues arising in securities offerings. She has advised domestic and non-U.S. issuers on regulatory requirements relating to compensation and benefits matters and assists clients with proxy disclosure, Section 16 compliance and corporate governance matters.
Melisa represents corporate clients, including Advanced Disposal Services, Inc., Altice USA, Inc., BofA Merrill Lynch, The Dow Chemical Company and the compensation comittee of Fannie Mae.
- KMG Chemicals on its acquisition by Cabot Microelectroincs Corporation for approximately $1.6 billion in a cash and stock merger transaction
- Altice USA, Inc. in its separation and spin-off from Altice N.V.
- Altice USA, Inc. in connection with the initial public offering of its Class A common stock
- BofA Merrill Lynch, as underwriters, in Homology Medicines Inc.’s and Y-mAbs Therapeutics, Inc.’s respective initial public offerings of common stock
- Sasol Limited in its registration of securities for issuance to employees
- The Dow Chemical Company in its internal restructuring following its merger with E. I. du Pont de Nemours and Company, its anticipated spin-off from DowDuPont Inc., the divestiture of its ethylene acrylic acid business to SK Global Chemical Co Ltd and the divestiture of its Building Solutions business to Ravago
- Compensation committees of Fannie Mae and Wells Fargo in relation to corporate governance matters
- Advanced Disposal Services, Inc., Altice USA, Inc. and Boston Scientific Corporation in relation to regular executive compensation, disclosure and governance advice
American University, Washington College of Law